BMO cuts CareTrust REIT stock price target on UK acquisition

LNT Care Developments sold 45 care homes to CareTrust REIT for £1.1bn. The deal includes 24 completed homes and 21 under development. LNT will continue managing the homes. The transaction aims to support further care home development in the UK, according to the companies.

KeyBanc reiterated an Overweight rating and $46.00 price target on CareTrust REIT (CTRE) after its $1.4B U.K. senior housing portfolio acquisition. The stock trades at $36.38, with projected high-teens earnings growth in 2026. Other analysts have mixed price target adjustments. CTRE has a PEG ratio of 0.75 and a 4.31% dividend yield.

CareTrust REIT (CTR) acquired 45 U.K. care homes for $1.5B, expanding its SHOP platform. The deal, with LNT Care, includes 24 homes closed on Oct. 1 and 21 under development. CTR aims to grow its U.K. portfolio to 33% of total properties, with senior housing reaching 40%.

CareTrust REIT agreed to acquire 45 UK care homes from LNT for £1.1bn. The deal includes 24 homes already purchased for £576m, with the remaining assets to be acquired next year upon completion.

Raymond James reduced its price target for CareTrust REIT (CTRE) to $42 from $45, citing higher capital costs. The stock trades at $36.30, with a 4.3% dividend yield. CTRE reported mixed Q2 2026 results, beating EPS estimates but missing on revenue. Analysts have mixed views on its valuation and growth prospects.

CareTrust REIT (CTRE) agreed to acquire 45 UK care homes from LNT Care Developments for approximately £1.1 billion. The deal includes an initial £576 million transaction for 24 homes, with the rest to be acquired by 2027. CareTrust funded the initial investment with equity proceeds and its revolving credit facility. The company raised its 2026 outlook, projecting net income of $1.54 to $1.57 per share and normalized funds from operations of $2.06 to $2.09 per share.